M. Elliott

发表

D 4476 , a cell-permeant inhibitor of CK 1 , suppresses the site-specific phosphorylationandnuclear exclusion of FOXO 1 a

P. Cohen, G. Rena, J. Bain, 2013 .

D4476, a cell‐permeant inhibitor of CK1, suppresses the site‐specific phosphorylation and nuclear exclusion of FOXO1a

P. Cohen, G. Rena, J. Bain, 2004, EMBO reports.

Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.

S. Moro, A. Brunati, J. Bain, 2004, Biochemistry.

The specificities of protein kinase inhibitors: an update.

P. Cohen, J. Bain, M. Elliott, 2003, The Biochemical journal.

Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1.

A. W. Schüttelkopf, D. V. van Aalten, D. Alessi, 2004, Structure.

The selectivity of protein kinase inhibitors: a further update.

P. Cohen, J. Arthur, D. Alessi, 2007, The Biochemical journal.

Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition.

David Komander, Dario R Alessi, D. V. van Aalten, 2003, The Biochemical journal.

Inhibition of Protein Kinase CK 2 by Condensed Polyphenolic Derivatives . An in Vitro and in Vivo Study †

S. Moro, A. Brunati, J. Bain, 2004 .

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

Miguel Correa Marrero, Robyn M. Kaake, Gwendolyn M. Jang, 2020, Science.

Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.

J. Bain, M. Elliott, L. Cesaro, 2004, Journal of medicinal chemistry.

The selectivity of inhibitors of protein kinase CK2: an update.

J. Bain, M. Elliott, L. Pinna, 2008, The Biochemical journal.

Mechanism of Action and Limited Cross-Resistance of New Lipopeptide MX-2401

W. Scott, C. Anklin, R. Hancock, 2011, Antimicrobial Agents and Chemotherapy.

Tetrabromocinnamic Acid (TBCA) and Related Compounds Represent a New Class of Specific Protein Kinase CK2 Inhibitors

S. Moro, J. Bain, M. Elliott, 2007, Chembiochem : a European journal of chemical biology.

ATP site-directed inhibitors of protein kinase CK2: an update.

J. Bain, M. Elliott, L. Pinna, 2011, Current topics in medicinal chemistry.

Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.

S. Moro, J. Bain, M. Elliott, 2009, The Biochemical journal.

Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).

D. Fabbro, P. Furet, J. Bain, 2003, The Biochemical journal.

A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research

D. Robertson, J. Hughes, D. Alessi, 2021, PLoS biology.

Comparison of the specificity of Trk inhibitors in recombinant and neuronal assays

J. Arthur, M. Elliott, N. Shpiro, 2011, Neuropharmacology.